ARCHIVES

Markison leaving Bristol-Myers, two others promoted in reorganization.

This article is from The Cancer Letter archive.

Vol. 30 No. 05 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

CCIRC Report Suggests Ways To Enhance Role Of Surgeons

July 22, 1977

New Patterns Of Care Study Okayed By DCT Board

June 13, 1986

Women Less Likely Than Men To Win Research Funding, Study Finds.

January 15, 2010

FASEB Says NIH Budge Should Reach $10 Bil. In Fiscal 1993

January 10, 1992

Trial Begins To Test Method To Test For Colorectal Cancer

May 28, 2004